U.S. pharma huge copyright scrapped two experimental weight loss drugs past year—a once-each day tablet, lotiglipron, on account of elevated liver enzymes and a twice-every day capsule, danuglipron, resulting from sturdy Unwanted effects—but CEO Albert Bourla has stated the company is determined to “Perform and get” during the weight proble